Briefly explain the function and the mechanism of action of proprotein convertase subtilisin/Kexin type 9 (PCSK9) and explain how it was initially identified in humans as an attractive target or dyslipidemia drug development. With diagram.
Briefly explain the function and the mechanism of action of proprotein convertase subtilisin/Kexin type 9 (PCSK9) and explain how it was initially identified in humans as an attractive target or dyslipidemia drug development. With diagram. Welcome to one of the…